- Down-rounds, Re-Pricings, and Recaps Increase — The current macroeconomic environment, coupled with record increases in valuations over the last several years, is creating an increase in down-rounds, re-pricings, and recapitalizations.
With the legendary success of technology giants born on campus, and the possibility that today’s college student could be tomorrow’s tech mogul, the academic world recognizes that it can be…
Continue Reading Academic Incubators Think Beyond Campus Borders to Spark Innovation
The past few years have seen an uptick in new accelerator and incubator programs that are focused on helping startups launch and grow. Participating in one of these programs can…
Continue Reading Incubator or Accelerator Program: Which Is Right for Your Business?
Structured exits are investment structures designed to achieve a desired investment return without reliance upon a traditional exit. Structured exit investments are ideal not only for impact investments, but also…
Continue Reading Structured Exits: A New Universe of Potential Funding for Companies in Underserved Markets
The Angel Capital Association (ACA) is the largest angel professional development organization in the world with over 12,000 members, 220 angel groups, and 10,000 early-stage companies in its members’ investment portfolios. Angel investing approximately equals that of venture capital investing, and has an enormous impact on the entrepreneurial eco-system in the United States and beyond.
For the second year, Greenberg Traurig has been a major sponsor of the ACA Summit, attended this year by over 600 angel investors from around the world who are leaders of their angel groups and represent thousands of investors. The firm sponsored the Innovation Showcase, which featured 28 innovative companies chosen by the NIH, NSF, and others. Greenberg Traurig’s team of David Gitlin, Craig Lilly, Jeff Joyner and Beth Cohen presented a workshop for the companies focused on the capital raising process, including valuation and term sheet issues, intellectual property protection, and alternative financing. The firm also hosted “office hours” with the companies, which enabled them to meet with the Greenberg Traurig team one on one to get legal input.
Continue Reading Greenberg Traurig Sponsors Angel Capital Association Summit
Emerging medical device companies should consider these points when weighing a potential merger, strategic partnership or investment:
1. Identify unmet medical needs
Medical device titans are actively looking to acquire new technologies to treat unmet medical needs and drive market adoption. Larger medtech companies often view early-stage companies as outsourced R&D labs, and will pay a premium price for products that can drive future revenue. The larger the potential market, the higher the value to medtech titans.
2. Know the market and competitors
Acquiring technologies that can transform or dominate a market drives many deals and collaborations. Disruptive technologies that improve patient outcomes are in high demand. Larger medtech companies are always on the lookout for new devices or improved treatments that have no or few competitors. Understanding the strategic investment goals and criteria of potential suitors will further refine and focus a growing medtech company’s efforts to gain visibility and generate productive relationships.
Continue Reading M&A, Investment or Partnering Checklist for Medtech Companies
On Nov. 5, 2014, the Boston office of Greenberg Traurig, LLP hosted a delegation from Portugal-based Venture Capital and Private Equity firm, Portugal Ventures, as part of a roadshow…
Continue Reading Boston Office Hosted Delegation from Portugal Ventures